Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging

Biomaterials

Volumn 31, Issue 7, 2010, Pages 1716-1722

  Xu, Jeff S ^a   Huang, Jiwei ^a   Qin, Ruogu ^a   Hinkle, George H ^b   Povoski, Stephen P ^b   Martin, Edward W ^b   Xu, Ronald X ^a  

^a Ohio State University   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Cancer targeting; Dual mode imaging; Fluorescence; Nanobubbles; Nanoparticles; Ultrasound

Indexed keywords

BINDING AFFINITIES; CANCER CELLS; CANCER IMAGING; CANCER-TARGETING; CONTRAST AGENT; DUAL MODES; DUAL-MODE IMAGING; GELATIN PHANTOMS; HUMAN COLON CANCER CELLS; IMAGING MODALITY; INTRA-OPERATIVE; LINEAR CORRELATION; NANO-BUBBLE; NANOBUBBLES; ONE-STEP PROCESS; POLY(LACTIC-CO-GLYCOLIC ACID); STREPTAVIDIN; TECHNICAL FEASIBILITY; THREE-STEP PROCESS; TUMOR BOUNDARY;

ACIDS; ACOUSTIC WAVES; ANTIBODIES; BINDING ENERGY; CELL CULTURE; CELLS; FLUORESCENCE; MEDICAL IMAGING; NANOPARTICLES; ULTRASONICS;

TUMORS;

ANTIBODY; CONTRAST MEDIUM; DYE; GELATIN; GLYCOPROTEIN; LIGAND; NANOBUBBLE; POLYGLACTIN; PROTEIN ANTIBODY; STREPTAVIDIN; TEXAS RED DYE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; BIOTINYLATION; CANCER CELL CULTURE; CANCER SURGERY; COLON CANCER; CONTROLLED STUDY; DRUG TARGETING; ENCAPSULATION; FLUORESCENCE; HUMAN; HUMAN CELL; IMAGING; INTRAOPERATIVE PERIOD; NANOFABRICATION; OPTICS; PHANTOM; PRIORITY JOURNAL; SIMULATOR; SYNTHESIS; ULTRASOUND;

CALIBRATION; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; GLYCOLATES; HUMANS; NANOSTRUCTURES; NEOPLASMS; SPECTROMETRY, FLUORESCENCE; ULTRASONICS; XANTHENES;

EID: 73249140369     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2009.11.052     Document Type: Article

References (51)

1. Carson P.L., and Giger M. Biomedical imaging research opportunities workshop: report and recommendations overview of the workshop. Acad Radiol 10 8 (2003) 882-886
2. Hendee W.R. Biomedical imaging research opportunities workshop III: summary of findings and recommendations. Radiology 238 2 (2006) 402-404
3. Xu R.X., and Povoski S.P. Diffuse optical imaging and spectroscopy for cancer. Expert Rev Med Devices 4 1 (2007) 83-95
4. Xu R.X., Qiang B., Mao J.J., and Povoski S.P. Development of a handheld near-infrared imager for dynamic characterization of in vivo biological tissue systems. Appl Opt 46 30 (2007) 7442-7451
5. Xu R.X., Young D.C., Mao J.J., and Povoski S.P. A prospective pilot clinical trial evaluating the utility of a dynamic near-infrared imaging device for characterizing suspicious breast lesions. Breast Cancer Res 9 6 (2007) R88
6. Wang B., Povoski S.P., Cao X., Sun D., and Xu R.X. Dynamic schema for near infrared detection of pressure-induced changes in solid tumors. Appl Opt 47 16 (2008) 3053-3063
7. Xu R.X., Ewing J., El-Dahdah H., Wang B., and Povoski S.P. Design and benchtop validation of a handheld integrated dynamic breast imaging system for noninvasive characterization of suspicious breast lesions. Tech Cancer Res Treat 7 6 (2008) 471-482
8. Zhu Q., Kurtzma S.H., Hegde P., Tannenbaum S., Kane M., Huang M., et al. Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers. Neoplasia 7 3 (2005) 263-270
9. Xu R.X., Povoski S.P., Yee L.D., Olsen J.O., Qiang B., and Mao J.M. Near infrared/ultrasound dual modal imaging for breast cancer detection. Proc SPIE 6081 (2006) 44-53
10. Zhu Q., Huang M., Chen N., Zarfos K., Jagjivan B., Kane M., et al. Ultrasound-guided optical tomographic imaging of malignant and benign breast lesions: initial clinical results of 19 cases. Neoplasia 5 5 (2003) 379-388
11. Johnson V.G., Schlom J., Paterson A.J., Bennett J., Magnani J.L., and Colcher D. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 46 2 (1986) 850-857
12. Lottich S.C., Johnston W.W., Szpak C.A., Delong E.R., Thor A., and Schlom J. Tumor-associated antigen TAG-72: correlation of expression in primary and metastatic breast carcinoma lesions. Breast Cancer Res Treat 6 1 (1985) 49-56
13. Slavin-Chiorini D.C., Kashmiri S.V., Lee H.S., Milenic D.E., Poole D.J., Bernon E., et al. A CDR-grafted (humanized) domain-deleted antitumor antibody. Cancer Biother Radiopharm 12 5 (1997) 305-316
14. Sun D., Bloomston M., Hinkle G., Al-Saif O.H., Hall N.C., Povoski S.P., et al. Radioimmunoguided surgery (RIGS), PET/CT image-guided surgery, and fluorescence image-guided surgery: past, present, and future. J Surg Oncol 96 4 (2007) 297-308
15. Martin Jr. E.W., and Thurston M.O. Intraoperative radioimmunodetection. Semin Surg Oncol 15 4 (1998) 205-208
16. Martinez D.A., Barbera-Guillem E., LaValle G.J., and Martin Jr. E.W. Radioimmunoguided surgery for gastrointestinal malignancies: an analysis of 14 years of clinical experience. Cancer Control 4 6 (1997) 505-516
17. Zou P., Xu S., Wang A., Povoski S., Johnson M., Martin E., et al. Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Mol Pharm 6 2 (2009) 428-440
18. Xu R.X., Huang J., Xu J.S., Sun D., Hinkle G.H., Martin E.W., et al. Fabrication of indocyanine green encapsulated biodegradable microbubbles for structural and functional imaging of cancer. J Biomed Opt 14 3 (2009) 034020
19. Campbell R.B. Tumor physiology and delivery of nanopharmaceuticals. Anticancer Agents Med Chem 6 6 (2006) 503-512
20. Unak T., Akgun Z., Yildirim Y., Duman Y., and Erenel G. Self-radioiodination of iodogen. Appl Radiat Isot 54 5 (2001) 749-752
21. Pisani E., Tsapis N., Paris J., Nicolas V., Cattel L., and Fattal E. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization. Langmuir 22 9 (2006) 4397-4402
22. Weiss B., Schneider M., Muys L., Taetz S., Neumann D., Schaefer U.F., et al. Coupling of biotin-(poly (ethylene glycol)) amine to poly (d, l-lactide-co-glycolide) nanoparticles for versatile surface modification. Bioconjug Chem 18 4 (2007) 1087-1094
23. Forsberg F., Merton D.A., Liu J.B., Needleman L., and Goldberg B.B. Clinical applications of ultrasound contrast agents. Ultrasonics 36 1-5 (1998) 695-701
24. Cohen J.L., Cheirif J., Segar D.S., Gillam L.D., Gottdiener J.S., Hausnerova E., et al. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter trial. J Am Coll Cardiol 32 3 (1998) 746-752
25. Villanueva F.S., Wagner W.R., Vannan M.A., and Narula J. Targeted ultrasound imaging using microbubbles. Cardiol Clin 22 2 (2004) 283-298
26. Schmitz G. Ultrasonic imaging of molecular targets. Basic Res Cardiol 103 2 (2008) 174-181
27. Lindner J.R., Song J., Xu F., Klibanov A.L., Singbartl K., Ley K., et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation 102 22 (2000) 2745-2750
28. Stride E., and Saffari N. Microbubble ultrasound contrast agents: a review. Proc Inst Mech Eng H 217 6 (2003) 429-447
29. Klibanov A.L., Rasche P.T., Hughes M.S., Wojdyla J.K., Galen K.P., Wible Jr. J.H., et al. Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles. Invest Radiol 39 3 (2004) 187-195
30. Ferrara K., Pollard R., and Borden M. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng 9 (2007) 415-447
31. Brannon-Peppas L., and Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56 11 (2004) 1649-1659
32. Lanza G.M., and Wickline S.A. Targeted ultrasonic contrast agents for molecular imaging and therapy. Curr Probl Cardiol 28 12 (2003) 625-653
33. Marsh J.N., Partlow K.C., Abendschein D.R., Scott M.J., Lanza G.M., and Wickline S.A. Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes. Ultrasound Med Biol 33 6 (2007) 950-958
34. Liu J., Li J., Rosol T.J., Pan X., and Voorhees J.L. Biodegradable nanoparticles for targeted ultrasound imaging of breast cancer cells in vitro. Phys Med Biol 52 16 (2007) 4739-4747
35. Kwon S, Wheatley MA. Development and characterization of PLG nano-dispersion as a potential ultrasound contrast agent for cancer site imaging. Proc IEEE Northeast Bioengineering Conference 2005;31:144-145.
36. Liu J., Levine A.L., Mattoon J.S., Yamaguchi M., Lee R.J., Pan X., et al. Nanoparticles as image enhancing agents for ultrasonography. Phys Med Biol 51 9 (2006) 2179-2189
37. Kawabata K.-I., Sugita N., Yoshikawa H., Azuma T., and Umemura S.-I. Nanoparticles with multiple perfluorocarbons for controllable ultrasonically induced phase shifting. Jpn J Appl Phys 44 6B (2005) 4548-4552
38. Gao Z., Kennedy A.M., Christensen D.A., and Rapoport N.Y. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics (2007)
39. Huang J, Xu JS, Xu RX. Heat-sensitive microbubbles for intraoperative assessment of cancer ablation margins. Biomaterials, in press, doi:10.1016/j.biomaterials.2009.11.008.
40. Goodwin D.A. Tumor pretargeting: almost the bottom line. J Nucl Med 36 5 (1995) 876-879
41. Gruaz-Guyon A., Raguin O., and Barbet J. Recent advances in pretargeted radioimmunotherapy. Curr Med Chem 12 3 (2005) 319-338
42. Bayer E.A., and Wilchek M. Application of avidin-biotin technology to affinity-based separations. J Chromatogr 510 (1990) 3-11
43. Hnatowich D.J., Virzi F., and Rusckowski M. Investigations of avidin and biotin for imaging applications. J Nucl Med 28 8 (1987) 1294-1302
44. Korpela J. Avidin, a high affinity biotin-binding protein, as a tool and subject of biological research. Med Biol 62 1 (1984) 5-26
45. Rosebrough S.F. Two-step immunological approaches for imaging and therapy. Q J Nucl Med 40 3 (1996) 234-251
46. Wilchek M., and Bayer E.A. Avidin-biotin technology ten years on: has it lived up to its expectations?. Trends Biochem Sci 14 10 (1989) 408-412
47. Hama Y., Urano Y., Koyama Y., Choyke P.L., and Kobayashi H. Activatable fluorescent molecular imaging of peritoneal metastases following pretargeting with a biotinylated monoclonal antibody. Cancer Res 67 8 (2007) 3809-3817
48. Bogusiewicz A., Mock N.I., and Mock D.M. Instability of the biotin-protein bond in human plasma. Anal Biochem 327 2 (2004) 156-161
49. Mock D.M., and Bogusiewicz A. Biotin-protein bond: instability and structural modification to provide stability for in vivo applications. Methods Mol Biol 418 (2008) 209-220
50. Stickney D.R., Anderson L.D., Slater J.B., Ahlem C.N., Kirk G.A., Schweighardt S.A., et al. Bifunctional antibody: a binary radiopharmaceutical delivery system for imaging colorectal carcinoma. Cancer Res 51 24 (1991) 6650-6655
51. Fang L., and Sun D. Predictive physiologically based pharmacokinetic model for antibody-directed enzyme prodrug therapy. Drug Metab Dispos 36 6 (2008) 1153-1165